A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

Clinical trial NCT06827236 · RECRUITING

Trial details

NCT number: NCT06827236
Sponsor: BioNTech SE
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Locally Advanced Breast Cancer Unresectable Breast Carcinoma Metastatic Breast Cancer

Start date: 2025-04-23
Primary completion: 2029-08-01
Enrollment: 380

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.